Clinical Trials Logo

Filter by:
NCT ID: NCT05837858 Completed - Biomarkers Clinical Trials

The Human Metabolic Profile and Gut Microbiota Under Various Dietary Quality

Start date: April 28, 2023
Phase: N/A
Study type: Interventional

The goal of this food intervention study is to screen/validate the whole grain food intake biomarker in health Chinese's population.

NCT ID: NCT05835934 Completed - Clinical trials for Peripheral Analgesic and Anti-itch

Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK21542 in Healthy Adult Male Volunteers.

Start date: June 15, 2021
Phase: Phase 1
Study type: Interventional

This is a single-center, nonrandomized, and open design study to investigate the pharmacokinetics, mass balance, metabolism and excretion of HSK21542 in healthy male subjects.

NCT ID: NCT05835115 Completed - Myopia Clinical Trials

Development and Validation of a Deep Learning-based Myopia and Myopic Maculopathy Detection and Prediction System

Start date: April 1, 2022
Phase:
Study type: Observational

Myopia has become a global public health issue. Myopia affects the psychological health of children and adolescents and poses a financial burden. Therefore, early detection and prediction of children at a high risk of myopia development and progression are critical for precise and effective interventions. In this study, we developed a deep learning system DeepMyopia, based on fundus images with the following objectives: 1) to predict myopia onset and progression; 2) To detect myopic macular degeneration for AI-assisted diagnosis; 3) To predict the development of myopic macular degeneration; 4) evaluate its cost-effectiveness.

NCT ID: NCT05834361 Completed - Clinical trials for Artificial Abortion, PONV(Post Operative Nausea and Vomiting)

The Time Point of Carboprost Methylate Administration and Perioperative Complications

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

Artificial abortion is the most widely used procedure in termination of first-trimester pregnancy. Cervical ripening before the operation guarantees operative convenience and decreases complications. An overstrained cervical dilation associates with uterine perforation, cervical laceration and cervical incompetence. To address the issue, various mechanical and pharmaceutical methods have been applied to prepare the cervix before transvaginal procedures. Prostaglandin analogues (PGs) play an important role in ripening the cervix or promoting uterine contraction in gynecology and obstetrics. As most tissues express prostaglandin receptors, vomiting, nausea, fever, diarrhea and abdominal pain can hardly be avoided with PGs administration. Longer PGs action contributes to better cervical ripening, but more uncomfortableness at the same time. These annoying symptoms may affect the participants' satisfaction and increase perioperative risks. To balance the safety and effectiveness of the surgery as well as patients' feeling, a proper timing for cervical ripening should be investigated. However, the administration timing of PGs has not reached a broad consensus, ranging from 16 hours to 2 hours before surgery. Carboprost methylate (CM), a PG-F2α analogue, has been used nationwide for cervical ripening in China. To minimize the side effects of PGs without affecting cervical ripening, the investigators intended to explore shortening the action time of CM in cervical preparation before artificial abortion. Thus, the investigators conducted this prospective cohort study and aimed to examine the efficacy of early and delayed vaginal administration of CM before surgery, and optimized both the perioperative safety and participants' convenience. The investigators hypothesize that early vaginal administration of CM would not affect the cervical ripening status, but will greatly reduce the unpleasant complications among the participants.

NCT ID: NCT05833308 Completed - Parkinson Disease Clinical Trials

Association Between Fibrinogen-to-albumin Ratio and Delirium After Deep Brain Stimulation Surgery in Parkinson's Disease

Start date: January 1, 2021
Phase:
Study type: Observational

Postoperative delirium (POD) remains one of the most common neuropsychiatric complications after deep brain stimulation (DBS) surgery. The fibrinogen-to-albumin ratio (FAR) has been shown to significantly correlate with prognosis of many diseases associated with inflammation, but the relationship between FAR and POD is unclear. The investigators aimed to investigate the association between POD and FAR in Parkinson's disease (PD) patients receiving DBS surgery. For this aim, the present study was conducted to provide a new method for the early recognition and perioperative management of delirium after DBS surgery in PD patients.

NCT ID: NCT05832853 Completed - Clinical trials for Frail Elderly Syndrome

A Study of the Intervention Effect of a Hybrid Exercise Program on Frail Elderly

Start date: May 20, 2018
Phase: N/A
Study type: Interventional

The declining physical condition of frail elderly is becoming an ugent problem. Although the exercise intensity of Wu Qin Xi appears to be low, it is highly effective in the older individuals. Inspired by the characteristics and functions of Wu Qin Xi, we designed a brand new exercise intervention training program among frail older people, which incorporates Wu Qin Xi, strength exercises and endurance exercises to improve physical fitness, and even reverse the condition of frailty. Furthermore, to improve utility in clinical practice, we innovatively employed machine learning simulations to infer the condition of older adults and predict their level of frailty after the intervention.

NCT ID: NCT05829551 Completed - Clinical trials for COVID-19 (Coronavirus Disease 2019)

The Safety, Tolerability and Pharmacokinetics Study of RAY1216 in Healthy Adult Participants

Start date: May 20, 2022
Phase: Phase 1
Study type: Interventional

This is double-blind,randomized, single and multiple dose trial to evaluate the pharmacokinetics(PK), safety, tolerability and drug-drug interaction of RAY1216, and the effect of food on RAY1216 Pharmacokinetics.

NCT ID: NCT05828485 Completed - Clinical trials for Paroxysmal Nocturnal Hemoglobinuria

Effect of Food on Pharmacokinetics of MY008211A Tablets in Healthy Adult Subjects

Start date: September 26, 2022
Phase: Phase 1
Study type: Interventional

This was a single-center, single-dose, open-label clinical study. 12 subjects were randomly assigned in a 1:1 ratio to one of the following dosing sequences (sequence 1: AB; Sequence 2: BA). Each dosing sequence consisted of two cycles, one dose per cycle, with a 5-day washout period between doses.

NCT ID: NCT05828472 Completed - Clinical trials for Paroxysmal Nocturnal Hemoglobinuria

A Study of Multiple Ascending Doses MY008211A in Healthy Adults

Start date: January 10, 2023
Phase: Phase 1
Study type: Interventional

This is a single-center, randomized, double-blind, placebo-controlled, dose-escalation, and multiple-dose study to evaluate safety, tolerability, PK and PD of MY008211A Tablets in healthy subjects.

NCT ID: NCT05828004 Completed - Clinical trials for Head and Neck Carcinoma

Effect of Whole-Course Multidisciplinary Care Intervention on Patients With Head and Neck Carcinoma

Start date: January 14, 2023
Phase: N/A
Study type: Interventional

Radiotherapy is one of the main treatments for head and neck Carcinoma. The incidence of radiotherapy-related adverse events is greater than 90%, and severe adverse events may lead to the interruption of radiotherapy. Interruption of radiotherapy on the one hand affects the efficacy of tumor treatment, on the other hand seriously affects the quality of life of patients. Investigators intend to conduct a randomized, controlled clinical study of multidisciplinary nutritional and psychological care for patients receiving radiotherapy for head and neck carcinoma, with a view to reducing the rate of radiotherapy interruption and improving the quality of life of patients with radiotherapy for head and neck carcinoma through a whole-course multidisciplinary care model.